Menu Search
Equities

Medicskin Holdings Ltd

8307:HKG.HS

Medicskin Holdings Ltd

Actions
  • Price (HKD)0.21
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-16.00%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Medicskin Holdings Limited is a Hong Kong-based investment holding company principally engaged in the provision of medical skin care services. The Company focuses on the treatment of skin diseases and problems, as well as the improvement of appearance. Skin diseases and problems include acne, pigmentation, rosacea, dermatitis, eczema and warts, among others. The improvement of appearance businesses include skin rejuvenation, facial sculpturing and body contouring treatments, the treatment of acne scars and enlarged pores and the removal of undesirable naevi and hair. The Company provides consultation services, prescription and dispensing services and treatment services. The Company mainly operates businesses in Hong Kong.

  • Revenue in HKD (TTM)50.08m
  • Net income in HKD-1.79m
  • Incorporated2014
  • Employees28.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.